The question of whether long-term exposure to testosterone therapy is associated with a significant increase in risk for a diagnosis of prostate cancer (and particularly clinically significant or high-risk prostate cancer) remains a matter of debate. A new paper by Baillargeon et al. in the Journal of Urology has added to our knowledge on this […]![]()
